J Lawrence

Summary

Country: USA

Publications

  1. ncbi request reprint Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons
    J Lawrence
    Center for AIDS Research at Stanford, Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA
    J Infect Dis 179:1356-64. 1999
  2. pmc Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment
    M A Winters
    Center for AIDS Research at Stanford, Stanford University, Stanford, California 94305, USA
    J Virol 72:5303-6. 1998

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons
    J Lawrence
    Center for AIDS Research at Stanford, Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA
    J Infect Dis 179:1356-64. 1999
    ..These results suggest that nelfinavir may have limited utility after saquinavir failure, particularly without potent concomitant therapy. Combining an NRTI with a new protease inhibitor for rescue may improve response...
  2. pmc Human immunodeficiency virus type 1 protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment
    M A Winters
    Center for AIDS Research at Stanford, Stanford University, Stanford, California 94305, USA
    J Virol 72:5303-6. 1998
    ..These results suggest that mutations selected in vivo by initial saquinavir therapy may provide more cross-resistance to the other protease inhibitors than has been previously reported...